October 12, 2015
Belfast, Northern Ireland-based Intelesens has received FDA 510(k) clearance for its wearable vital signs monitor, called zensor, designed for monitoring patients outside the hospital.
“This is a significant milestone for Intelesens and zensor," Intelesens Commercial Manager Stephen Henderson said in a statement. "...Not only does FDA clearance give the company access to the world’s biggest...
April 15, 2015
Intelesens's Zensor device.
Scanadu and Intelesens (makers of the Zensor device), two of the ten finalists for the Qualcomm Tricorder X Prize, have merged their teams into one as the competition enters the home stretch. It wraps up in 2016.
"Intelesens and Scanadu have been working together informally for a while," Shannon Wolf Montague, Commercial Manager at Intelesense, told MobiHealthNews...
August 27, 2014
The finalists have been announced for the Qualcomm Tricorder X Prize, lowering the field from 22 companies that had not yet dropped out to just 10 that will compete for the $10 million prize in a series of hands-on trials of their handheld, smartphone-connected diagnostic devices designed for consumer use.
“This is an extremely hard competition,” Dr. Erik Viirre, technical and medical director...